Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer

International Journal of Cancer

Volumn 136, Issue 4, 2015, Pages 875-879

  Guzel, Esra ^a,b   Karatas, Omer F ^a,c   Semercioz, Atilla ^d   Ekici, Sinan ^e   Aykan, Serdar ^d   Yentur, Serhat ^d   Creighton, Chad J ^f   Ittmann, Michael ^f   Ozen, Mustafa ^a,b,f  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BIRUNI UNIVERSITY   (Turkey)

^c ERZURUM TECHNICAL UNIVERSITY   (Turkey)

^d Bagcilar Education and Research Hospital   (Turkey)

^e MALTEPE UNIVERSITY   (Turkey)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; Diagnostic biomarkers; Microrna; Prostate cancer

Indexed keywords

MICRORNA; MICRORNA 133B; MICRORNA 203; MICRORNA 221; MICRORNA 361 3P; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; MICROARRAY ANALYSIS; PREDICTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SECRETION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; METABOLISM; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SECRETION (PROCESS);

AGED; AREA UNDER CURVE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DOWN-REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84918827158     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29054     Document Type: Article

References (30)

1. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36
2. Bhatnagar N, Li X, Padi SK, et al. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis 2010;1:e105
3. Valencia-Sanchez MA, Liu J, Hannon GJ, et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515-24
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
5. Griffiths-Jones S, Saini HK, van Dongen S, et al. miRBase: Tools for microRNA genomics. Nucleic Acids Res 2008;36:D154-8
6. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-7
7. Mallory AC, Vaucheret H. Functions of micro- RNAs and related small RNAs in plants. Nat Genet 2006;38 Suppl:S31-6
8. Brennecke J, Hipfner DR, Stark A, et al. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003; 113:25-36
9. Chen ZH, Zhang GL, Li HR, et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate 2012;72: 1443-52
10. Karatas OF, Guzel E, Karaca E, et al. MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients. Mol Biol Rep 2013
11. Majid S, Dar AA, Saini S, et al. MicroRNA-205- directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 2010; 116:5637-49
12. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010; 126:1283-90
13. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009;27:5848-56
14. Makarov DV, Loeb S, Getzenberg RH, et al. Biomarkers for prostate cancer. Annu Rev Med 2009; 60:139-51
15. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-A survey. Biochim Biophys Acta 2007;1775:181-232
16. Weber JA, Baxter DH, Zhang S, et al. The micro- RNA spectrum in 12 body fluids. Clin Chem 2010;56:1733-41
17. Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta 1985;822:203-18
18. Zaneveld LJ, Tauber PF. Contribution of prostatic fluid components to the ejaculate. Prog Clin Biol Res 1981;75A:265-77
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8
20. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8
21. Chen ZH, Zhang GL, Li HR, et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate 2012
22. Mahn R, Heukamp LC, Rogenhofer S, et al. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011;77: 1265 e9-16
23. Roth C, Stuckrath I, Pantel K, et al. Low levels of cell-free circulating miR-361-3p and miR-625.∗ as blood-based markers for discriminating malignant from benign lung tumors. PLoS One 2012;7: e38248
24. Patron JP, Fendler A, Bild M, et al. MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS One 2012;7: e35345
25. Boll K, Reiche K, Kasack K, et al. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 2013;32:277-85
26. Viticchie G, Lena AM, Latina A, et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011;10:1121-31
27. Iorio MV, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007;67:8699-707
28. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-36
29. Galardi S, Mercatelli N, Farace MG, et al. NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res 2011;39: 3892-902
30. Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010;126:1166-76.